Media Center

Lu WeiJia shared his journey from a university laboratory in Hong Kong to the industry. He said that his initial intention in conducting research was to address the real needs of patients. Seeing how his technologies helped bone fracture patients relieve pain further strengthened his determination to translate academic research into practical applications.

Bone’s 2026 Annual Innovation and Development Conference was successfully held. All team members gathered under one roof, reviewed the past, painted a blueprint, expressed their advancement, and focused their efforts. This injected strong momentum into high-quality development for the coming year.

2026, New Beginnings in Bone Health, The Future Awaits!

Professor Lu Weijia's team and Dr. Lin Junyu have achieved groundbreaking results in bone quality research, injecting transformative momentum into the field of orthopedics.

Over 30 orthopedic experts jointly completed the final review and consensus confirmation of the 'Guidelines' before its release.

Bone’s participated in top-tier industry exchanges with a dual focus on 'academic presentations + product exhibitions'.

Bone's QCT products aligns with new policy requirements, providing efficient and precise tools for the early detection and health management of chronic diseases such as osteoporosis.

Bone’s team presented research findings at the poster exhibition area, emphasizing 'dose adaptation' as a core advantage, generating widespread interest in the industry.

We look forward to collaborating with industry peers to promote the adoption of the new guidelines, driving the diagnosis and treatment of osteoporotic fractures to a more precise and safer future.

The first QCT bone density software certified in Hong Kong!

This project aims to benefit patients with lumbar spine diseases and contribute technological strength to the "Healthy Jiangxi" initiative.

The story of Lu Weijia and Bone serves as a prime example of the countless ‘barrier breakers’ in this city. These individuals push the boundaries of science and technology to benefit humanity, standing as a vivid embodiment of health.

Bone’s will leverage this opportunity for academic exchange to continuously deepen collaboration with industry peers, enhance innovation and competitiveness, and safeguard people's health.

Bone’s has reached a deep collaborative consensus with strategic partners and will leverage innovative products and premium services as dual engines to achieve sustainable, mutually beneficial value!

Bone’s will continue to delve into the field of digital healthcare, empowering precision orthopedics with technological innovation to safeguard patients' health!

The world's first clinical diagnostic tool centered on "3D Quantification + Localized Precision Testing"!

From standardized treatment to technological innovation, from expert dedication to grassroots empowerment, this academic event has injected new momentum into the prevention and treatment of osteoporosis.

Moving forward, to the next scenic stop, we hope to journey with you~

Reflecting on 2024, Bone’s achieved comprehensive breakthroughs in technological innovation, market expansion, and research collaborations, empowered orthopedic health management with digital technology, and realized high-quality development.

Bone’s team was invited to participate in HKU's PHC Health Summit, sharing innovations in AI diagnostics for bone health and engaging in in-depth discussions with HKU School of Medicine experts on new models of industry-academia-research collaboration.

At the global bone health academic conference, Bone’s showcased innovative research achievements, leading the way in orthopedic diagnostics and prevention, and advancing the formulation of industry standards.

Bone’s introduces new AI medical technology to unlock CT data with one click, providing a more accurate and user-friendly solution for bone density testing.

Bone’s and multiple partner hospitals jointly presented the latest research findings on osteoporosis diagnosis at the International ISRRT World Congress.